1). Gabriel SE., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009. 11:229.
Article
2). Dagfinrud H., Mengshoel AM., Hagen KB., Loge JH., Kvien TK. Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis. 2004. 63:1605–10.
3). Mackay K., Brophy S., Mack C., Doran M., Calin A. The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the Bath Ankylosing Spondylitis Radiology Hip index. J Rheumatol. 2000. 27:2866–72.
4). Creemers MC., Franssen MJ., van't Hof MA., Gribnau FW., van de Putte LB., van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005. 64:127–9.
Article
5). Wanders A., Landerwe R., Spoorenbeg A., de Vlam K., Mielants H., Dougados M, et al. Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order. Ann Rheum Dis. 2004. 63:1601–4.
Article
6). Salaffi F., Carotti M., Garofalo G., Giuseppetti GM., Grassi W. Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol. 2007. 25:67–74.
7). Chandran V., O'Shea FD., Schentag CT., Inman RD., Gladman DD. Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a comparative analysis. J Rheumatol. 2007. 34:2463–5.
8). Brophy S., Mackay K., Al-Saidi A., Taylor G., Calin A. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol. 2002. 29:1236–43.
9). Doran MF., Brophy S., Mackay K., Taylor G., Calin A. Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol. 2003. 30:316–20.
10). Ward MM., Hendrey MR., Malley JD., Learch TJ., Davis JC Jr., Reveille JD, et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum. 2009. 61:859–66.
Article
11). Lee W., Reveile JD., Davis JC Jr., Learch TJ., Ward MM., Weisman MH. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis. 2007. 66:633–8.
Article
12). Lee HS., Kim TH., Yun HR., Park YW., Jung SS., Bae SC, et al. Radiologic changes of cervical spine in ankylosing spondylitis. Clin Rheumatol. 2001. 20:262–6.
Article
13). Jung YO., Kim I., Kim S., Suh CH., Park HJ., Park W, et al. Clinical and radiographic features of adult-onset ankylosing spondylitis in Korean patients: comparisons between males and females. J Korean Med Sci. 2010. 25:532–5.
Article
14). Baek HJ., Shin KC., Lee YJ., Kang SW., Lee EB., Yoo CD, et al. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology (Oxford). 2004. 43:1526–31.
Article
15). Baek HJ., Shin KC., Lee YJ., Kang SW., Lee EB., Yoo CD, et al. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J Rheumatol. 2002. 29:1780–5.
16). van der Linden S., Valkenburg HA., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis; a proposal for modification of the modified New York criteria. Arthritis Rheum. 1984. 27:361–8.
17). Kim H., Kim S., Jee SH. The independent effects of cigarette smoking, alcohol consumption, and serum aspartate aminotransferase on the alanine aminotransferase ratio in Korean men for the risk for esophageal cancer. Yonsei Med J. 2010. 51:310–7.
Article
18). Gensler LS., Ward MM., Reveille JD., Learch TJ., Weisman MH., Davis JC Jr. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis. 2008. 67:233–7.
Article
19). Kim TJ., Na KS., Lee HJ., Lee B., Kim TH. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol. 2009. 27:574–9.
20). Landewe R., Dougados M., Mielants H., van der Tempel H., van der Heijde D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis. 2009. 68:863–7.
Article
21). Sampaio-Barros PD., Bertolo MB., Kraemer MH., Neto JF., Samara AM. Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol. 2001. 28:560–5.
22). Brophy S., Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001. 28:2283–8.
23). Calin A., Mackay K., Santos H., Brophy S. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol. 1999. 26:988–93.
24). Amor B., Santos R., Nahal R., Listrat V., Dougados M. Predictive factors for the long-term outcome of spondyloarthropathies. J Rheumatol. 1994. 21:1883–7.
25). Boonen A., vander Cruyssen B., de Vlam K., Steinfeld S., Ribbens C., Lenaerts J, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009. 36:1249–55.
Article
26). Smith JA., Marker-Hermann E., Colbert RA. Patholgenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol. 2006. 20:571–91.
27). Calin A., Fries JF., Schuman D., Payne R. The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol. 1977. 4:277–81.
28). Russell AS., Lentile BC., Schlaut J. Radiologic and scintiscan findings in HLA-B27 negative patients with ankylosing spondylitis. J Rheumatol. 1976. 3:321–3.
29). Averns H., Oxtoby J., Taylor H., Jones P., Dziedzic K., Dawes P. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol. 1996. 25:138–42.
Article
30). Baraliakos X., Davis J., Tsuji W., Braun J. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum. 2005. 52:1216–23.
31). Lambert RG., Salonen D., Rahman P., Inman RD., Wong RL., Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007. 56:4005–14.
Article